ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
336 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2025-02-16 (cmshs-bloggt.de)
UPC: Overview of current judgments and developments -
The number of decisions of the uniform patent court (Unified Patent Court, UPC) increases steadily. Our overview represents the orders and decisions of the UPC.
Read more
2021-07-16 (chemistanddruggist.co.uk)
Accord vows to appeal CMA verdict on 10,000% hydrocortisone price hiking | Chemist+Druggist
Auden Mckenzie and Actavis UK (now Accord-UK) increased the price of 10mg and 20mg hydrocortisone tablets by more than 10,000% for almost a decade, a CMA investigation has found.
Read more
2017-11-08 (lifesciencesipreview.com)
Accord loses patent invalidation battle at English court
Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High Court.
Read more
2013-05-02 (accord-healthcare.com)
Accord Healthcare Ltd. has successfully resolved the case ...
Accord. A Judgment in the case was handed down by the Court of Appeal on the 30th of April and confirms the decision of the UK High Court in March 2012 that AstraZeneca’ s patent is invalid, allowing Accord Healthcare UK to launch its generic version
Read more
(juve-patent.com)
Alcon wins with Bristows over glaucoma drug patent validity -
The UK High Court has upheld in revocation proceeding a patent owned by Alcon, which covers a drug used to treat the eye condition glaucoma.
Read more